SIST EN ISO 13408-1:2015

SLOVENSKI STANDARD
01-september-2015
1DGRPHãþD
SIST EN ISO 13408-1:2011
SIST EN ISO 13408-1:2011/A1:2013
$VHSWLþQDSURL]YRGQMDL]GHONRY]D]GUDYVWYHQRQHJRGHO6SORãQH]DKWHYH,62
YNOMXþQR]$PG
Aseptic processing of health care products - Part 1: General requirements (ISO 13408-
1:2008, including Amd 1:2013)
Aseptische Herstellung von Produkten für die Gesundheitsfürsorge - Teil 1: Allgemeine
Anforderungen (ISO 13408-1:2008)
Traitement aseptique des produits de santé - Partie 1: Exigences générales (ISO 13408-
1:2008, y compris Amd 1:2013)
Ta slovenski standard je istoveten z: EN ISO 13408-1:2015
ICS:
11.080.01 Sterilizacija in dezinfekcija na Sterilization and disinfection
splošno in general
2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.

EUROPEAN STANDARD
EN ISO 13408-1
NORME EUROPÉENNE
EUROPÄISCHE NORM
June 2015
ICS 11.080.01 Supersedes EN ISO 13408-1:2011
English Version
Aseptic processing of health care products - Part 1: General
requirements (ISO 13408-1:2008, including Amd 1:2013)
Traitement aseptique des produits de santé - Partie 1: Aseptische Herstellung von Produkten für die
Exigences générales (ISO 13408-1:2008, y compris Amd Gesundheitsfürsorge - Teil 1: Allgemeine Anforderungen
1:2013) (ISO 13408-1:2008, einschließlich Amd 1:2013)
This European Standard was approved by CEN on 20 May 2015.

CEN members are bound to comply with the CEN/CENELEC Internal Regulations which stipulate the conditions for giving this European
Standard the status of a national standard without any alteration. Up-to-date lists and bibliographical references concerning such national
standards may be obtained on application to the CEN-CENELEC Management Centre or to any CEN member.

This European Standard exists in three official versions (English, French, German). A version in any other language made by translation
under the responsibility of a CEN member into its own language and notified to the CEN-CENELEC Management Centre has the same
status as the official versions.

CEN members are the national standards bodies of Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia,
Finland, Former Yugoslav Republic of Macedonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania,
Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and United
Kingdom.
EUROPEAN COMMITTEE FOR STANDARDIZATION
COMITÉ EUROPÉEN DE NORMALISATION

EUROPÄISCHES KOMITEE FÜR NORMUNG

CEN-CENELEC Management Centre: Avenue Marnix 17, B-1000 Brussels
© 2015 CEN All rights of exploitation in any form and by any means reserved Ref. No. EN ISO 13408-1:2015 E
worldwide for CEN national Members.

Contents Page
Foreword . 2
Annex ZA (informative) Relationship between this European Standard and the Essential
Requirements of EU Directive 90/385/EEC on active implantable medical devices . 4
Annex ZB (informative) Relationship between this European Standard and the Essential
Requirements of EU Directive 93/42/EEC on medical devices . 5
Annex ZC (informative) Relationship between this European Standard and the Essential
Requirements of EU Directive 98/79/EC on in vitro diagnostic medical devices . 6

Foreword
The text of ISO 13408-1:2008, including Amd 1:2013 has been prepared by Technical Committee
ISO/TC 198 “Sterilization of health care products” of the International Organization for Standardization
(ISO) and has been taken over as EN ISO 13408-1:2015 by Technical Committee CEN/TC 204
“Sterilization of medical devices” the secretariat of which is held by BSI.
This European Standard shall be given the status of a national standard, either by publication of an
identical text or by endorsement, at the latest by December 2015, and conflicting national standards shall
be withdrawn at the latest by December 2015.
Attention is drawn to the possibility that some of the elements of this document may be the subject of
patent rights. CEN [and/or CENELEC] shall not be held responsible for identifying any or all such patent
rights.
This document supersedes EN ISO 13408-1:2011.
This document has been prepared under a mandate given to CEN by the European Commission and the
European Free Trade Association, and supports essential requirements of EU Directives.
For relationship with EU Directives, see informative Annexes ZA, ZB and ZC, which are integral parts of
this document.
The following referenced documents are indispensable for the application of this document. For undated
references, the edition of the referenced document (including any amendments) listed below applies. For
dated references, only the edition cited applies. However, for any use of this standard within the meaning of
Annex ZA, ZB or ZC, the user should always check that any referenced document has not been
superseded and that its relevant contents can still be considered the generally acknowledged state-of-art.
When an IEC or ISO standard is referred to in the ISO standard text, this should be understood as a
normative reference to the corresponding EN standard, if available, and otherwise to the dated version of
the ISO or IEC standard as listed below.
NOTE The way in which these referenced documents are cited in normative requirements determines the extent
(in whole or in part) to which they apply.
Table — Correlation between normative references and dated EN and ISO standards
Normative references Equivalent dated standard
as listed in Clause 2 of the ISO
EN ISO
standard
ISO 9001 EN ISO 9001:2008 ISO 9001:2008
ISO 11135 EN ISO 11135:2014 ISO 11135:2014
ISO 11137-1 EN ISO 11137-1:2006 + A1:2013 ISO 11137-1:2006 + A1:2013
ISO 11137-2 EN ISO 11137-2:2013 ISO 11137-2:2013
ISO 13408-2 EN ISO 13408-2:2011 ISO 13408-2:2011
ISO 13408-3 EN ISO 13408-3:2011 ISO 13408-3:2011
ISO 13408-4 EN ISO 13408-4:2011 ISO 13408-4:2011
ISO 13408-5 EN ISO 13408-5:2011 ISO 13408-5:2011
ISO 13408-6 EN ISO 13408-6:2011 + A1:2013 ISO 13408-6:2011 + A1:2013
Normative references Equivalent dated standard
as listed in Clause 2 of the ISO
EN ISO
standard
ISO 13485 EN ISO 13485:2012 ISO 13485:2003
ISO 14160 EN ISO 14160:2011 ISO 14160:2011
ISO 14644-1 EN ISO 14644-1:1999 ISO 14644-1:1999
ISO 14644-2 EN ISO 14644-2:2000 ISO 14644-2:2000
ISO 14644-3 EN ISO 14644-3:2005 ISO 14644-3:2005
ISO 14644-4 EN ISO 14644-4:2001 ISO 14644-4:2001
ISO 14644-5 EN ISO 14644-5:2004 ISO 14644-5:2004
ISO 14644-7 EN ISO 14644-7:2004 ISO 14644-7:2004
ISO 14698-1 EN ISO 14698-1:2003 ISO 14698-1:2003
ISO 14698-2 EN ISO 14698-2:2003 + A1:2006 ISO 14698-2:2003 + A1:2006
ISO 14937 EN ISO 14937:2009 ISO 14937:2009
ISO 14971 EN ISO 14971:2012 ISO 14971:2007
ISO 17665-1 EN ISO 17665-1:2006 ISO 17665-1:2006
ISO 20857 EN ISO 20857:2013 ISO 20857:2013
Regarding the reference to ICH Q9: Guidance for Industry — Quality Risk Management, this should be
considered to be the edition published in 2006.
According to the CEN-CENELEC Internal Regulations, the national standards organizations of the following
countries are bound to implement this European Standard: Austria, Belgium, Bulgaria, Croatia, Cyprus,
Czech Republic, Denmark, Estonia, Finland, Former Yugoslav Republic of Macedonia, France, Germany,
Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway,
Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and the United
Kingdom.
Endorsement notice
The text of ISO 13408-1:2008, including Amd 1:2013 has been approved by CEN as EN ISO 13408-1:2015
without any modification.
Annex ZA
(informative)
Relationship between this European Standard and the Essential
Requirements of EU Directive 90/385/EEC on active implantable
medical devices
This European Standard has been prepared under a mandate given to CEN/CENELEC by the European
Commission and the European Free Trade Association to provide a means of conforming to Essential
Requirements of the New Approach Directive 90/385/EEC on active implantable medical devices.
Once this standard is cited in the Official Journal of the European Union under that Directive and has been
implemented as a national standard in at least one Member State, compliance with the normative clauses
of this standard given in Table ZA.1 confers, within the limits of the scope of this standard, a presumption of
conformity with the corresponding Essential Requirements of that Directive and associated EFTA
regulations.
NOTE 1 Where a reference from a clause of this standard to the risk management process is made, the risk
management process needs to be in compliance with 90/385/EEC, as amended by 2007/47/EC. This means that risks
have to be reduced ‘as far as possible’, ‘to a minimum’, ‘to the lowest possible level’, ‘minimized’ or ‘removed’,
according to the wording of the corresponding essential requirement.
NOTE 2 The manufacturer’s policy for determining acceptable risk must be in compliance with essential
requirements 1, 4, 5, 8, 9 and 10 of the Directive.
NOTE 3 This Annex ZA is based on normative references according to the table of references in the European
foreword, replacing the references in the core text.
NOTE 4 When an Essential Requirement does not appear in Table ZA.1, it means that it is not addressed by this
European Standard.
Table ZA.1 — Correspondence between this European Standard and Directive 90/385/EEC
Clauses of this EN Essential Requirements Qualifying remarks/Notes
(ERs) of Directive
90/385/EEC
4,5,6,7,8,9,10,11 7 Only attainment of sterility by aseptic processing
is considered by this standard.
This relevant Essential Requirement is only
partly addressed in this European Standard.
Design and packaging for maintenance of
sterility during transportation and storage are not
covered. Aspects of manufacture other than
those related to sterilization are not covered.
WARNING — Other requirements and other EU Directives may be applicable to the product(s) falling
within the scope of this Standard.
Annex ZB
(informative)
Relationship between this European Standard and the Essential
Requirements of EU Directive 93/42/EEC on medical devices
This European Standard has been prepared under a mandate given to CEN/CENELC by the European
Commission and the European Free Trade Association to provide a means of conforming to Essential
Requirements of the New Approach Directive 93/42/EEC on medical devices.
Once this standard is cited in the Official Journal of the European Union under that Directive and has been
implemented as a national standard in at least one Member State, compliance with the normative clauses
of this standard given in Table ZB.1 confers, within the limits of the scope of this standard, a presumption of
conformity with the corresponding Essential Requirements of that Directive and associated EFTA
regulations.
NOTE 1 Where a reference from a clause of this standard to the risk management process is made, the risk
management process needs to be in compliance with 93/42/EEC, as amended by 2007/47/EC. This means that risks
have to be reduced ‘as far as possible’, ‘to a minimum’, ‘to the lowest possible level’, ‘minimized’ or ‘removed’,
according to the wording of the corresponding essential requirement.
NOTE 2 The manufacturer’s policy for determining acceptable risk must be in compliance with essential
requirements 1, 2, 5, 6, 7, 8, 9, 11 and 12 of the Directive.
NOTE 3 This Annex ZA is based on normative references according to the table of references in the European
foreword, replacing the references in the core text.
NOTE 4 When an Essential Requirement does not appear in Table ZA.1, it means that it is not addressed by this
European Standard.
Table ZB.1 — Correspondence between this European Standard and Directive 93/42/EEC
Clauses of this EN Essential Requirements Qualifying remarks/Notes
(ERs) of Directive 93/42/EEC
4,5,6,7,8,9,10,11 8.3 Only attainment of sterility by aseptic processing
is considered by this standard.
This relevant Essential Requirement is only partly
addressed in this European Standard. Design
and packaging for maintenance of sterility during
transportation and storage are not covered.
Aspects of manufacture other than those related
to sterilization are not covered.
4,5,6,7,8,9,10,11 8.4 This relevant Essential Requirement is only partly
addressed in this European Standard. Aspects of
manufacture other than those related to
sterilization are not covered.
WARNING — Other requirements and other EU Directives may be applicable to the product(s) falling
within the scope of this Standard.
Annex ZC
(informative)
Relationship between this European Standard and the Essential
Requirements of EU Directive 98/79/EC on in vitro diagnostic
medical devices
This European Standard has been prepared under a mandate given to CEN/CENELEC by the European
Commission and the European Free Trade Association to provide a means of conforming to Essential
Requirements of the New Approach Directive 98/79/EC on in vitro diagnostic medical devices.
Once this standard is cited in the Official Journal of the European Union under that Directive and has been
implemented as a national standard in at least one Member State, compliance with the normative clauses
of this standard given in Table ZC.1 confers, within the limits of the scope of this standard, a presumption
of conformity with the corresponding Essential Requirements of that Directive and associated EFTA
regulations.
NOTE 1 Where a reference from a clause of this standard to the risk management process is made, the risk
management process needs to be
...